Regenicin, Inc. is a biotechnology company, which specializing in the development of regenerative cell therapies to restore the health of damaged tissues and organs. It intends to develop and commercialize a potentially lifesaving technology by the introduction of tissue-engineered skin substitutes to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds and a variety of plastic surgery procedures. The company was founded on September 6, 2007 and is headquartered in Little Falls, NJ.
Company profile
Ticker
RGIN
Exchange
Website
CEO
Randall E. McCoy
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Windstar Inc.
SEC CIK
RGIN stock data
Latest filings (excl ownership)
8-K
Changes in Registrant's Certifying Accountant
14 Sep 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-Q
2023 Q1
Quarterly report
13 Feb 23
10-K
2022 FY
Annual report
13 Jan 23
NT 10-K
Notice of late annual filing
27 Dec 22
10-Q
2022 Q3
Quarterly report
12 Aug 22
10-Q
2022 Q2
Quarterly report
23 May 22
NT 10-Q
Notice of late quarterly filing
16 May 22
10-K/A
2021 FY
Annual report (amended)
25 Mar 22
Financial summary
Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Sep 22 | Sep 21 | Sep 20 | Sep 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 10.88 mm | 10.88 mm | 10.88 mm | 10.88 mm | 10.88 mm | |
Cash burn (monthly) | (no burn) | 112.15 k | 64.30 k | (no burn) | 28.66 k | |
Cash used (since last report) | n/a | 1.43 mm | 821.82 k | n/a | 366.35 k | |
Cash remaining | n/a | 9.45 mm | 10.06 mm | n/a | 10.51 mm | |
Runway (months of cash) | n/a | 84.2 | 156.4 | n/a | 366.8 |
Institutional ownership, Q2 2023
0.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 7.60 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Bartlett & Co. | 7.60 k | $0.00 |